JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
Phillips 66
PSX
$93.2B
| $3.63M | ﹤0.01% |
50,100
| – | – |
|
3202
PUT
Bristol-Myers Squibb
BMY
$130B
| $3.63M | ﹤0.01% |
58,200
| – | – |
|
3203
PUT
Illinois Tool Works
ITW
$82.8B
| $3.63M | ﹤0.01% |
14,700
| – | – |
|
|
ADVM
3204
DELISTED
Adverum Biotechnologies
ADVM
| $3.63M | ﹤0.01% |
206,096
-20,561
| -9% | -$412K |
|
|
AUS
3205
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $3.62M | ﹤0.01% |
372,502
-677,498
| -65% | -$6.69M |
|
3206
Core Laboratories
CLB
$571M
| $3.6M | ﹤0.01% |
161,529
+110,894
| +219% | +$2.89M |
|
3207
Corsair Gaming
CRSR
$1.41B
| $3.6M | ﹤0.01% |
171,251
+43,267
| +34% | +$1.03M |
|
3208
Lyell Immunopharma
LYEL
$342M
| $3.59M | ﹤0.01% |
23,218
+6,114
| +36% | +$1.36M |
|
3209
Fulcrum Therapeutics
FULC
$285M
| $3.59M | ﹤0.01% |
202,873
+29,146
| +17% | +$577K |
|
3210
Innoviz Technologies
INVZ
$107M
| $3.58M | ﹤0.01% |
+564,218
| New | +$3.23M |
|
3211
PUT
Unity
U
$20.4B
| $3.58M | ﹤0.01% |
25,000
-336,700
| -93% | -$51.5M |
|
3212
Global X Silver Miners ETF NEW
SIL
$4.79B
| $3.57M | ﹤0.01% |
97,286
+7,660
| +9% | +$290K |
|
3213
CALL
Teladoc Health
TDOC
$1.24B
| $3.56M | ﹤0.01% |
38,801
| – | – |
|
3214
St. Joe Company
JOE
$3.89B
| $3.56M | ﹤0.01% |
68,398
+19,886
| +41% | +$964K |
|
3215
PUT
SiriusXM
SIRI
$9.59B
| $3.56M | ﹤0.01% |
+56,000
| New | +$3.5M |
|
3216
Dime Commercial Bancshares
DCOM
$1.81B
| $3.55M | ﹤0.01% |
101,062
-3,958
| -4% | -$139K |
|
3217
PUT
International Paper
IP
$21.6B
| $3.55M | ﹤0.01% |
75,640
+48,184
| +175% | +$2.38M |
|
3218
Goosehead Insurance
GSHD
$2.35B
| $3.55M | ﹤0.01% |
27,268
-1,520
| -5% | -$218K |
|
3219
Ingles Markets
IMKTA
$1.65B
| $3.54M | ﹤0.01% |
41,041
+20,474
| +100% | +$1.56M |
|
3220
iShares MSCI Europe Small-Cap ETF
IEUS
$185M
| $3.54M | ﹤0.01% |
50,840
-2,495
| -5% | -$174K |
|
|
MRNS
3221
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.54M | ﹤0.01% |
298,121
-13,804
| -4% | -$159K |
|
3222
3D Systems Corp
DDD
$616M
| $3.53M | ﹤0.01% |
164,040
-3,774
| -2% | -$95.2K |
|
|
MCFE
3223
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $3.53M | ﹤0.01% |
136,910
-2,536
| -2% | -$61.1K |
|
3224
iShares US Financials ETF
IYF
$4.43B
| $3.52M | ﹤0.01% |
40,647
-6,944
| -15% | -$605K |
|
3225
First Interstate BancSystem
FIBK
$3.73B
| $3.52M | ﹤0.01% |
86,516
-4,702
| -5% | -$195K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.